The COVID-R3ICSAB Study: COVID‑19 Wide Impact: Research on the Risk and Resilience In Special Communities of Chinese, South Asian and Black Populations Liu, Peter P | Ottawa Heart Institute Research Corporation | Operating Grant | $498,210 CIHR Ontario 2022 Read More
COVID-19 Variant Supplement – Improving Outcomes in Individuals with COVID‑19 with Renin-Angiotensin System Inhibition: The COVID-RASi Trial Liu, Peter P | Ottawa Heart Institute Research Corporation | Operating Grant | $50,000 CIHR Ontario 2021 Read More
Improving Outcomes in Individuals with COVID‑19 with Renin-Angiotensin System Inhibition: The COVID-RASi Trial Liu, Peter P | Ottawa Heart Institute Research Corporation | Operating Grant | $1,176,019 CIHR Ontario 2020 Read More